Μπορείτε να στέλνετε ειδήσεις και Δελτία Τύπου στο email μας.
Αν θέλετε να επικοινωνήσετε μαζί μας ή να στείλετε Δελτίο Τύπου πατήστε εδώ...pharmamarketingexpertsblog@gmail.com


Τετάρτη 30 Οκτωβρίου 2019

Top 9 Drugs With the Biggest Price Increases Over 2 Years


Nine widely-used medications have experienced substantial price surges over the past 2 years, adding $5.1 billion to overall drug spending during this time period, according to a new report.
The authors of the report, the Institute of Clinical and Economic Review (ICER) claimed 7 of the 9 drugs were lacking sufficient clinical evidence to support such price increases, but several pharmaceutical manufacturers took issue with the methodology used in the analysis.

Of the drugs listed, the ICER indicated that lenalidomide and dimethyl fumarate were the only 2 with new clinical evidence. In appendix published with the report, however, several manufacturers challenged ICER's methodology and findings. For example, the assessment only includes indications representing greater than 10% of use, not accounting for smaller indications such as rare diseases that may reflect improvements in net health benefit.